Ventana Medical's Automation Gamble
Executive SummaryVentana hopes to acheive big-time diagnostics success by bringing automation to the overlooked esoteric fields of immunohistochemistry and in situ hybridization. Like its predecessors in other segments of diagnostics, it faces resistance from potential customers who grumble about expensive, closed systems.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.